about
Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation.Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier.Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer.Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.Fusion of multi-tracer PET images for dose painting.Automatic Measurement of the Total Visceral Adipose Tissue From Computed Tomography Images by Using a Multi-Atlas Segmentation Method.18F-FDG-PET partial volume effect correction using a modified recovery coefficient approach based on functional volume and local contrast: physical validation and clinical feasibility in oncology.Monte-Carlo simulations of clinically realistic respiratory gated (18)F-FDG PET: application to lesion detectability and volume measurements.Segmentation of heterogeneous or small FDG PET positive tissue based on a 3D-locally adaptive random walk algorithm.Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET.A new approach for dose calculation in targeted radionuclide therapy (TRT) based on collapsed cone superposition: validation with (90)Y.Optimisation of the OS-EM algorithm and comparison with FBP for image reconstruction on a dual-head camera: a phantom and a clinical 18F-FDG study.Reproducibility of the adaptive thresholding calibration procedure for the delineation of 18F-FDG-PET-positive lesions.Voxeldoes: a computer program for 3-D dose calculation in therapeutic nuclear medicine.Use of subtraction ictal SPECT co-registered to MRI for optimizing the localization of seizure foci in children.Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.Edge detection in brain SPET perfusion imaging: a comparison of several methods.Proportional anatomical stereotactic atlas for visual interpretation of brain SPET perfusion images.Implementation and validation of collapsed cone superposition for radiopharmaceutical dosimetry of photon emitters.Validation of the Monte Carlo simulator GATE for indium-111 imaging.Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.Semiautomated thoracic and abdominal computed tomography segmentation using the belief functions theory: application to 3D internal dosimetry.Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients.In vitro assessment of a 3D segmentation algorithm based on the belief functions theory in calculating renal volumes by MRI.Comparative study of three automatic programs of left ventricular ejection fraction evaluation.Adjuvant I-131 Lipiodol After Resection or Radiofrequency Ablation for Hepatocellular Carcinoma.Segmentation of biological target volumes on multi-tracer PET images based on information fusion for achieving dose painting in radiotherapyDosimetry at the cellular level of Kupffer cells after technetium-99m-sulphur colloid injectionPharmacokinetics and tissue distribution of 99mTc-labelled enoxaparin in the rat: evaluation of dosimetry parametersThe influence of tracer localization on the electron dose rate delivered to the cell nucleusAbsorbed fraction to the cell nucleus for low energy electronsA place for cellular dosimetry in risk assessmentComparison of cytogenetic damage in cultured cells from cobalt-60 gamma-radiation and the Auger emitter zinc-65Comparison between 2D and 3D dosimetry protocols in 90Y-ibritumomab tiuxetan radioimmunotherapy of patients with non-Hodgkin's lymphoma[Magnetic resonance urography in children]Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC)FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy dosesHigh FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancerTumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma
P50
Q33768719-710EE1E2-38E3-4AB8-906C-D1072676A9C0Q35841199-0C8180B4-F880-4176-8BFD-2B353AEAECE7Q36304217-68345335-F5B0-4BA2-BB35-F12540B52B9FQ37681293-A63E260F-D9F0-4A84-8F5C-66CEFAC4F373Q38418023-144B9D37-A50D-45CE-94D6-AD4D0E5BC69DQ38419258-F8EAE7F1-9706-4FB3-8180-FDC036CC346FQ38678947-E2A1A71C-FC76-4E88-892E-26FCD1772D4EQ40500832-5654BE80-57C0-4FFB-B42D-CA3BF9EFB682Q41743678-3B077BFB-A675-427A-9DAD-3319ADF3B993Q41754549-4BDDB708-88AF-462D-B65B-7BE5DDD862A9Q43191889-D07BB099-F0D4-4283-9506-6D1E80760D56Q43866409-30B6501E-D72F-4952-94F1-248A82432298Q44632436-1E561734-1B0B-4BF9-B8C4-4292A3B035E9Q45753960-5A4A003C-2334-4D37-B5C6-845DD1DB86C0Q47995603-852A2595-D5AB-4D50-9411-CEBB0469F276Q48216767-97B9F562-D767-4EAB-821E-79A68AB02DFEQ48222205-388C16B4-6DB4-4754-A88C-A62292BD6D3BQ48524703-84CFDB64-5966-473C-A398-B019879F8277Q48958705-56A3DD7E-279F-45E9-8CCF-F296967B0957Q50848473-1F1C5764-F21B-4ABE-B195-663AB45A74ABQ51426049-984807F7-93D9-403C-97C0-1A2CAAD436B7Q51605253-9F420AB5-5AAE-43F6-9027-5A4A0F41F136Q51626231-07F99C0F-F000-455A-B7A1-23F4DCBB499FQ51697954-91606CE9-71CC-4DD5-A148-613A9FFC522AQ51870916-7F7BE5E4-44C2-4E88-8F85-0B83B27C6330Q52335189-94538021-272C-449C-AE1E-7DE7B5016417Q53118350-DC168DCE-4822-4644-B0E4-D6B9EBF54798Q57129794-1A68519B-8B42-4173-994D-95ECFDA0EA29Q67755376-5AAE124C-8F71-4EA3-889F-CC278BDDDC51Q68482671-1F70EB20-9E8B-4397-B3EE-1F8695449766Q72681605-F755ECC2-E7D6-4D6B-A80F-AD601EA91221Q73002097-448D95DB-4C6D-4D76-8828-8B58EB44D620Q74017537-0F677DA1-3BFB-4B5C-B014-091AF619B244Q74332062-D4060FF6-5571-4FAE-B1D2-A340B6118DE0Q80768386-9563AA78-0217-4DB8-AFC8-E2313AAF519EQ83336028-A667B38F-B5D9-4996-919A-C82F093ADEB8Q84873422-FDC4BAFC-EDA4-4CB6-BAD5-16C8659134BCQ86040822-414417E3-8640-442F-945A-D6886CB81D65Q86725295-76CAAF1D-7AAF-4ABC-BA21-BB5BFEAE8A75Q88504663-962F2B12-70A6-4D13-9EBD-85AD15F485DA
P50
description
researcher ORCID ID = 0000-0002-6342-6127
@en
wetenschapper
@nl
name
Isabelle Gardin
@ast
Isabelle Gardin
@en
Isabelle Gardin
@es
Isabelle Gardin
@nl
type
label
Isabelle Gardin
@ast
Isabelle Gardin
@en
Isabelle Gardin
@es
Isabelle Gardin
@nl
prefLabel
Isabelle Gardin
@ast
Isabelle Gardin
@en
Isabelle Gardin
@es
Isabelle Gardin
@nl
P106
P31
P496
0000-0002-6342-6127